HECTOROL Side Effects

7020102-3 | Vomiting
on Sep 17, 2010 Male patient from UNITED STATES , weighting 220.5 lb, was diagnosed with secondary hypothyroidism, hyperparathyroidism secondary, hyperphosphataemia and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: vomiting. Hectorol dosage: 1 Mcg, Tiw. During the same period patient was treated with CINACALCET (30 Mg, Qd) (View Cinacalcet Review and Cinacalcet Label ), SEVELAMER (1.6 G, Tid) (View Sevelamer Review and Sevelamer Label ). Patient was hospitalized.

6958223-3 | Blood Parathyroid Hormone Increased
Patient was taking Hectorol (View Usage). Patient had the following side effects: blood parathyroid hormone increased on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 250.0 lb, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 1.0 Mcg, Qd. During the same period patient was treated with CLONIDINE (0.2 Mg, Tid) (View Clonidine Review and Clonidine Label ), LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ), ATENOLOL (50 Mg, Qd) (View Atenolol Review and Atenolol Label ), HYDRALAZINE HCL (50 Mg, Tid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), HUMALOG MIX (Unk) (View Humalog Mix Review and Humalog Mix Label ), PRAVASTATIN (20 Mg, Qd) (View Pravastatin Review and Pravastatin Label ).

6835852-9 | Abdominal Pain Upper
Adverse event was reported on Jul 02, 2010 by a Male patient taking Hectorol (View Usage) (Dosage: 1.0 Mcg, Qd) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 86 years of age, After Hectorol was administered, patient had the following side effects: abdominal pain upper. Patient was hospitalized.

6756028-X | Loss Of Consciousness, Medical Device Complication
on May 27, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, medical device complication. Hectorol dosage: 11 Mcg, Tiw. Patient was hospitalized.


6696694-0 | Abdominal Pain Upper
on Apr 16, 2010 Male patient from UNITED STATES , 86 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient had the following side effects: abdominal pain upper. Hectorol dosage: 1.0 Mcg, Qd. Patient was hospitalized.

6537112-2 | Blood Magnesium Decreased
Patient was taking Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: blood magnesium decreased on Dec 29, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 0.5 Mcg, 5x/w, Oral. Patient was hospitalized.

6480257-6 | Blood Pressure Decreased, Depressed Level Of Consciousness, Dysphagia, Gastrointestinal Tube Insertion, Oxygen Saturation Decreased, Rales, Sepsis
Adverse event was reported on Nov 18, 2009 by a Female patient taking Hectorol (View Usage) (Dosage: 2 Mcg/ml, Qd) was diagnosed with secondary hypothyroidism and. Location: UNITED STATES , 66 years of age, weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, depressed level of consciousness, dysphagia, gastrointestinal tube insertion, oxygen saturation decreased, rales, sepsis (What is sepsis?). During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), DICLOFENAC (DICLOFENAC) (View Diclofenac (diclofenac) Review and Diclofenac (diclofenac) Label ), CRESTOR (View Crestor Review and Crestor Label ), TEHTAMA HCT (View Tehtama Hct Review and Tehtama Hct Label ), CLARITIN (View Claritin Review and Claritin Label ), CEREFOLIN NAC (View Cerefolin Nac Review and Cerefolin Nac Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), AZOR (ALPRAZOLAM) (View Azor (alprazolam) Review and Azor (alprazolam) Label ). Patient was hospitalized and became disabled.

6480255-2 | Blood Pressure Decreased, Depressed Level Of Consciousness, Dysphagia, Rales, Sepsis
on Nov 18, 2009 Female patient from UNITED STATES , 66 years of age, weighting 200.0 lb, was diagnosed with secondary hypothyroidism and was treated with Hectorol (View Usage). Patient had the following side effects: blood pressure decreased, depressed level of consciousness, dysphagia, rales, sepsis (What is sepsis?). Hectorol dosage: 2 Mcg/ml, Qd. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), DICLOFENAC (DICLOFENAC) (View Diclofenac (diclofenac) Review and Diclofenac (diclofenac) Label ), CRESTOR (View Crestor Review and Crestor Label ), TEHTAMA HCT (View Tehtama Hct Review and Tehtama Hct Label ), CLARITIN (View Claritin Review and Claritin Label ), CEREFOLIN (View Cerefolin Review and Cerefolin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), AZOR (ALPRAZOLAM) (View Azor (alprazolam) Review and Azor (alprazolam) Label ). Patient was hospitalized and became disabled.

6358560-X | Gastrostomy Tube Insertion
on Sep 02, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: gastrostomy tube insertion. Hectorol dosage: . Patient was hospitalized.

6312485-4 | Cardiopulmonary Failure
Patient was taking Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure on Aug 04, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: Oral.

6308228-0 | Blood Parathyroid Hormone Increased, Blood Phosphorus Increased, Convulsion, Hypercalcaemia, Muscle Twitching
Adverse event was reported on Jul 28, 2009 by a Male patient taking Hectorol (View Usage) (Dosage: 1 Mcg, Intravenous; 5 Mcg, Intravenous; 4 Mcg, Intravenous) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 58 years of age, weighting 137.8 lb, Patient had the following side effects: blood parathyroid hormone increased, blood phosphorus increased, convulsion, hypercalcaemia, muscle twitching. During the same period patient was treated with SENSIPAR (View Sensipar Review and Sensipar Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6291340-2 | Chest Pain
on May 20, 2009 Male patient from UNITED STATES , 52 years of age, was diagnosed with off label use and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: chest pain (What is chest pain?). Hectorol dosage: 1000 Mcg, Qd, Oral. During the same period patient was treated with COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6287539-1 | Cerebrovascular Accident
on Jul 13, 2009 Female patient from UNITED STATES , 81 years of age, was diagnosed with hyperparathyroidism secondary, renal failure and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Hectorol dosage: 0.5 Mcg, 3x/w, Oral. Patient was hospitalized.

6274426-8 | Blood Pressure Increased, Refusal Of Treatment By Patient, Respiratory Distress
Patient was taking Hectorol (View Usage). Patient had the following side effects: blood pressure increased, refusal of treatment by patient, respiratory distress on Jul 02, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: Intravenous. During the same period patient was treated with SENSIPAR (View Sensipar Review and Sensipar Label ), LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), PHOSLO (View Phoslo Review and Phoslo Label ), COREG (View Coreg Review and Coreg Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), STRESSTABS (VITAMIN NOS) (View Stresstabs (vitamin Nos) Review and Stresstabs (vitamin Nos) Label ).

6235699-0 | Anaphylactic Reaction, Food Allergy
Adverse event was reported on Jun 04, 2009 by a Male patient taking Hectorol (View Usage) (Dosage: 6 Mcg, 2x/w, Intravenous, 4 Mcg, 2x/w) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 53 years of age, After Hectorol was administered, patient had the following side effects: anaphylactic reaction, food allergy (What is food allergy?).

6204036-X | Blood Parathyroid Hormone Increased, Convulsion, Hypercalcaemia
on May 07, 2009 Male patient from UNITED STATES , 58 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: blood parathyroid hormone increased, convulsion, hypercalcaemia. Hectorol dosage: 4 Mcg, Intravenous. During the same period patient was treated with SENSIPAR (View Sensipar Review and Sensipar Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), BABY ASPIRIN (ACETLYSALICYLIC ACID) (View Baby Aspirin (acetlysalicylic Acid) Review and Baby Aspirin (acetlysalicylic Acid) Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6058045-4 | Pruritus
on Jan 15, 2009 Male patient from UNITED STATES , 79 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient had the following side effects: pruritus. Hectorol dosage: 0.5 Mcg Qod Oral. During the same period patient was treated with AMLODIPINE (AMLODIPINE MESILATE) (View Amlodipine (amlodipine Mesilate) Review and Amlodipine (amlodipine Mesilate) Label ), FLOMAX (View Flomax Review and Flomax Label ), FUROSEMIDE (FUROSEMIDE SODIUM) (View Furosemide (furosemide Sodium) Review and Furosemide (furosemide Sodium) Label ). Patient was hospitalized.

6053365-1 | Lip Swelling, Respiratory Disorder
Patient was taking Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: lip swelling, respiratory disorder on Jan 05, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 6 Mcg, 2x/w, Intravenous 4 Mcg, 2x/w, Intravenous.

5945758-5 | Blood Calcium Decreased, Dizziness, Inner Ear Disorder
Adverse event was reported on Oct 23, 2008 by a Male patient taking Hectorol (View Usage) (Dosage: 0.5 Mcg, Qd, Oral) was diagnosed with hypoparathyroidism and. Location: UNITED STATES , 54 years of age, Patient experienced the following unwanted or unexpected effects: blood calcium decreased, dizziness (What is dizziness?), inner ear disorder. Patient was hospitalized.

5881020-7 | Dizziness
on Sep 02, 2008 Male patient from UNITED STATES , 54 years of age, was diagnosed with hypoparathyroidism and was treated with Hectorol (View Usage). Patient had the following side effects: dizziness (What is dizziness?). Hectorol dosage: 0.5 Mcg, Qd; Oral. Patient was hospitalized.

5498426-0 | Cardiopulmonary Failure, Central Nervous System Infection, Nipple Pain
on Oct 10, 2007 Male patient from UNITED STATES , 75 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: cardiopulmonary failure, central nervous system infection, nipple pain. Hectorol dosage: 2.5 Mcg Tiw Po.

5466366-9 | Accidental Exposure, Blood Parathyroid Hormone Increased, Diarrhoea, Nausea, Vision Blurred
Patient was taking Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, blood parathyroid hormone increased, diarrhoea, nausea (What is nausea?), vision blurred on Sep 11, 2007 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 5.5. Mcg Once Iv. During the same period patient was treated with ZEMPLAR (View Zemplar Review and Zemplar Label ).

5417390-3 | Nipple Pain
Adverse event was reported on Aug 02, 2007 by a Male patient taking Hectorol (View Usage) (Dosage: 2.5 Mcg Tiw Po) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 75 years of age, Patient had the following side effects: nipple pain.

5410299-0 | Accidental Exposure, Diarrhoea, Nausea, Vision Blurred
on Jul 27, 2007 Male patient from UNITED STATES , 43 years of age, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: accidental exposure, diarrhoea, nausea (What is nausea?), vision blurred. Hectorol dosage: 5.5 Mcg Once Iv. During the same period patient was treated with ZEMPLAR (View Zemplar Review and Zemplar Label ).

5407942-9 | Arteriovenous Fistula Site Complication, Bacteraemia, Cardiovascular Disorder, Catheter Related Complication, Catheter Site Discharge, Haematocrit Decreased, Haemodialysis, Haemoglobin Decreased, Staphylococcal Infection
on Jul 24, 2007 Female patient from UNITED STATES , 45 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: arteriovenous fistula site complication, bacteraemia, cardiovascular disorder, catheter related complication, catheter site discharge, haematocrit decreased, haemodialysis, haemoglobin decreased, staphylococcal infection (What is staphylococcal infection?). Hectorol dosage: 0.25 Mg. During the same period patient was treated with ACTIVASE (View Activase Review and Activase Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

5362849-0 | Blood Parathyroid Hormone Increased, Cardiac Disorder, Dizziness, Hyperhidrosis, Paranoia, Pruritus
Patient was taking Hectorol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, cardiac disorder, dizziness (What is dizziness?), hyperhidrosis, paranoia, pruritus on Jun 07, 2007 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 1 Mcg Daily Po. During the same period patient was treated with ZEMPLAR. MFR: ABBOTT LABORATORIES (View Zemplar. Mfr: Abbott Laboratories Review and Zemplar. Mfr: Abbott Laboratories Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ). Patient was hospitalized.

5341031-7 | Blood Parathyroid Hormone Increased, Cardiac Disorder, Dizziness, Hyperhidrosis, Pruritus
Adverse event was reported on May 16, 2007 by a Male patient taking Hectorol (View Usage) (Dosage: 1 Mcg Daily Po) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 79 years of age, After Hectorol was administered, patient had the following side effects: blood parathyroid hormone increased, cardiac disorder, dizziness (What is dizziness?), hyperhidrosis, pruritus. During the same period patient was treated with ZEMPLAR (View Zemplar Review and Zemplar Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ). Patient was hospitalized.

5335551-9 | Arteriovenous Fistula Operation, Hyperparathyroidism, Muscular Weakness, Overdose
on May 10, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: arteriovenous fistula operation, hyperparathyroidism, muscular weakness, overdose. Hectorol dosage: 2.5 Mcg 3x/w Po.

5294514-2 | Dialysis, Hyperparathyroidism, Incorrect Dose Administered, Muscular Weakness, Overdose
on Mar 28, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient had the following side effects: dialysis (What is dialysis?), hyperparathyroidism, incorrect dose administered, muscular weakness, overdose. Hectorol dosage: 2.5 Mcg 3x/w Po.

5292662-4 | Arrhythmia
Patient was taking Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: arrhythmia (What is arrhythmia?) on Mar 21, 2007 from UNITED STATES Additional patient health information: Male patient , 47 years of age, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 4 Mcg 2x/w Iv.

5213084-8 | Blood Parathyroid Hormone Increased
Adverse event was reported on Jul 19, 2006 by a Male patient taking Hectorol (View Usage) (Dosage: 6 Mcg 3x/w Iv) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 32 years of age, weighting 144.4 lb, Patient experienced the following unwanted or unexpected effects: blood parathyroid hormone increased.

5213059-9 | Aortic Valve Replacement, Coronary Artery Bypass, Gangrene, Peripheral Vascular Disorder, Sepsis
on Jan 02, 2007 Female patient from UNITED STATES , 67 years of age, was diagnosed with hyperphosphataemia and was treated with Hectorol (View Usage). Patient had the following side effects: aortic valve replacement, coronary artery bypass (What is coronary artery bypass?), gangrene, peripheral vascular disorder, sepsis (What is sepsis?). Hectorol dosage: . During the same period patient was treated with RENAGEL (1.6 G Tid Po) (View Renagel Review and Renagel Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), REPLIVA (View Repliva Review and Repliva Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ), EPOGEN (View Epogen Review and Epogen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), COREG (View Coreg Review and Coreg Label ).

5213046-0 | Blood Parathyroid Hormone Increased
on Jan 03, 2007 Male patient from UNITED STATES , 51 years of age, weighting 183.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: blood parathyroid hormone increased. Hectorol dosage: 6 Mcg 3x/w Iv. During the same period patient was treated with SENSIPAR (CINACALCET HYDROCHLORIDE) (View Sensipar (cinacalcet Hydrochloride) Review and Sensipar (cinacalcet Hydrochloride) Label ).

5189818-8 | Aortic Valve Replacement, Coronary Artery Bypass, Gangrene, Peripheral Vascular Disorder, Sepsis
Patient was taking Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve replacement, coronary artery bypass (What is coronary artery bypass?), gangrene, peripheral vascular disorder, sepsis (What is sepsis?) on Dec 04, 2006 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with hyperphosphataemia and. Hectorol dosage: . During the same period patient was treated with RENAGEL (2.4 G Tid Po) (View Renagel Review and Renagel Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), REPLIVA (View Repliva Review and Repliva Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ), EPOGEN (View Epogen Review and Epogen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), COREG (View Coreg Review and Coreg Label ).

5149039-1 | Hypercalcaemia, Metastatic Neoplasm, Serum Ferritin Increased
Adverse event was reported on Apr 06, 2006 by a Female patient taking Hectorol (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 54 years of age, Patient had the following side effects: hypercalcaemia, metastatic neoplasm, serum ferritin increased. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), PHOSLO (View Phoslo Review and Phoslo Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5060307-4 |
on Jul 06, 2006 Male patient from UNITED STATES , 47 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). . Hectorol dosage: 4 Mcg 2x/w Iv.

5028193-6 | Anxiety, Diabetic Nephropathy, Nephritis Interstitial, Nervousness, Pollakiuria, Renal Failure Chronic, Renal Impairment, Soft Tissue Disorder, Swelling
on May 30, 2006 Male patient from UNITED STATES , 53 years of age, weighting 266.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), diabetic nephropathy, nephritis interstitial, nervousness, pollakiuria, renal failure chronic, renal impairment, soft tissue disorder, swelling. Hectorol dosage: 2.5 Mcg Qd Po. During the same period patient was treated with AMBIEN (View Ambien Review and Ambien Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), HUMALOG (View Humalog Review and Humalog Label ), NIASPAN (View Niaspan Review and Niaspan Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), LANTUS (INSULIN GLARGINE SYSTEMIC) (View Lantus (insulin Glargine-systemic) Review and Lantus (insulin Glargine-systemic) Label ).

4999491-7 | Confusional State, Convulsion, Mental Status Changes, Pneumonia Aspiration, Psychotic Disorder, Speech Disorder, Unresponsive To Verbal Stimuli
Patient was taking Hectorol (View Usage). Patient had the following side effects: confusional state, convulsion, mental status changes, pneumonia aspiration, psychotic disorder (What is psychotic disorder?), speech disorder, unresponsive to verbal stimuli on Apr 25, 2006 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 141.1 lb, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 2 Mcg 3x/w Iv. Patient was hospitalized.

4975879-5 | Hypercalcaemia, Metastatic Neoplasm, Serum Ferritin Increased
Adverse event was reported on Mar 28, 2006 by a Female patient taking Hectorol (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 54 years of age, After Hectorol was administered, patient had the following side effects: hypercalcaemia, metastatic neoplasm, serum ferritin increased. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), PHOSLO (View Phoslo Review and Phoslo Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

4838486-0 | Anxiety, Blood Pressure Diastolic Increased, Blood Pressure Systolic Increased, Condition Aggravated, Nephritis Interstitial, Nervousness, Pollakiuria, Renal Failure Chronic, Renal Impairment
on Nov 14, 2005 Male patient from UNITED STATES , 53 years of age, weighting 266.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood pressure diastolic increased, blood pressure systolic increased, condition aggravated, nephritis interstitial, nervousness, pollakiuria, renal failure chronic, renal impairment. Hectorol dosage: 2.5 Mcg Qd Po. During the same period patient was treated with AMBIEN (View Ambien Review and Ambien Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), HUMALOG (View Humalog Review and Humalog Label ), NIASPAN (View Niaspan Review and Niaspan Label ), HYDROCODONE ACETAMINOPHEN (View Hydrocodone Acetaminophen Review and Hydrocodone Acetaminophen Label ), LANTUS (INSULIN GLARGINE SYSTEMIC) (View Lantus (insulin Glargine-systemic) Review and Lantus (insulin Glargine-systemic) Label ).

4838485-9 | Nephritis Interstitial, Pruritus
on Nov 14, 2005 Male patient from UNITED STATES , 51 years of age, weighting 204.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient had the following side effects: nephritis interstitial, pruritus. Hectorol dosage: 0.5 Mg Qd Po. During the same period patient was treated with SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), OMEGA 3 FATTY ACIDS (View Omega-3 Fatty Acids Review and Omega-3 Fatty Acids Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), COREG (View Coreg Review and Coreg Label ), PLAVIX (View Plavix Review and Plavix Label ).

4834890-5 | Nephritis Interstitial
Patient was taking Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: nephritis interstitial on Oct 31, 2005 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 2.5 Mcg Qd Po.

4834849-8 | Nephritis Interstitial
Adverse event was reported on Oct 31, 2005 by a Male patient taking Hectorol (View Usage) (Dosage: 0.5 Mcg Qd Po) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: nephritis interstitial.

4815994-X | Haemodialysis, Infection, Intestinal Obstruction, Pruritus
on Jun 08, 2005 Female patient from UNITED STATES , 83 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). Patient had the following side effects: haemodialysis, infection (What is infection?), intestinal obstruction, pruritus. Hectorol dosage: 2 Mcg 3x/w Iv.

4793941-7 | Hypotension, Pruritus
on Jul 21, 2005 Female patient from UNITED STATES , 48 years of age, weighting 223.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: hypotension, pruritus. Hectorol dosage: 6 Mcg 3x/w Iv. During the same period patient was treated with ATORAX (View Atorax Review and Atorax Label ), MEDRALL (View Medrall Review and Medrall Label ), ZOCOR (View Zocor Review and Zocor Label ), ULTRAN (View Ultran Review and Ultran Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), NEPHROVITE (View Nephrovite Review and Nephrovite Label ), MIDONINE (View Midonine Review and Midonine Label ).

4789032-1 | Abdominal Pain, Blood Parathyroid Hormone Increased, Blood Phosphorus Increased, Gait Disturbance, Knee Operation, Muscle Injury
Patient was taking Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood parathyroid hormone increased, blood phosphorus increased, gait disturbance, knee operation, muscle injury on Jul 21, 2005 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 127.9 lb, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 4 Mcg 3x/w Iv. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), LOVENOX (View Lovenox Review and Lovenox Label ), EPOGEN (View Epogen Review and Epogen Label ), PLENDIL (View Plendil Review and Plendil Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), HEPARIN (View Heparin Review and Heparin Label ), 2% NITROGLYCERIN OINTMENT (View 2% Nitroglycerin Ointment Review and 2% Nitroglycerin Ointment Label ). Patient was hospitalized.

4751193-8 | Pancreatitis
Adverse event was reported on Nov 08, 2001 by a Female patient taking Hectorol (View Usage) (Dosage: 10 Mcg Qod, Iv) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , 56 years of age, weighting 180.0 lb, Patient had the following side effects: pancreatitis. During the same period patient was treated with HUMULIN (View Humulin Review and Humulin Label ), RENAGEL (View Renagel Review and Renagel Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

4724536-9 | Blood Pressure Decreased, Depressed Level Of Consciousness, Haemodialysis, Infusion Related Reaction, Throat Tightness
on Jul 13, 2005 Male patient from UNITED STATES , weighting 178.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with Hectorol (View Usage). After Hectorol was administered, patient had the following side effects: blood pressure decreased, depressed level of consciousness, haemodialysis, infusion related reaction, throat tightness. Hectorol dosage: 3 Mcg 3 X/week Iv/many Doses. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), PLAVIX (View Plavix Review and Plavix Label ), RENAGEL TABLETS (View Renagel Tablets Review and Renagel Tablets Label ), ALTACE (View Altace Review and Altace Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), RENAVITE (View Renavite Review and Renavite Label ), LASIX (View Lasix Review and Lasix Label ).

4685322-1 | Dizziness, Nausea
on Jun 06, 2005 Female patient from , 48 years of age, weighting 149.0 lb, was treated with Hectorol (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?). Hectorol dosage: Po Qid (0.5 Mg). During the same period patient was treated with CALCITRIOL (Bid One (0.25 Mg)) (View Calcitriol Review and Calcitriol Label ).

4684216-5 | Fatigue, Hypercalcaemia, Mental Status Changes
Patient was taking Hectorol (View Usage). Patient had the following side effects: fatigue, hypercalcaemia, mental status changes on Apr 16, 2004 from Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and. Hectorol dosage: 4 Mcg; 3 X/week; Iv. Patient was hospitalized.